Phase II study of antineoplaston A10 and AS2-1 in patients with non-Hodgkin's lymphoma, intermediate-grade
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 26 Sep 2017 Status changed from active, no longer recruiting to discontinued.
- 06 Oct 2005 New trial record.